Globular adiponectin activates Akt in cultured myocytes

Biochemical and Biophysical Research Communications

Volumn 424, Issue 4, 2012, Pages 753-757

  Sattar, Akm A ^a   Sattar, Rifat ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adiponectin; Akt; AMPK; Insulin; Phosphorylation; Wortmannin

Indexed keywords

ADIPONECTIN; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TIME; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ADIPONECTIN; ANDROSTADIENES; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; INSULIN; MUSCLE FIBERS, SKELETAL; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

RATTUS;

EID: 84864819158     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.027     Document Type: Article

References (32)

1. Felber J.P., Haesler E., Jequier E. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993, 36:1221-1229.
2. Goodpaster B.H., Kelley D.E. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?. Curr Diab Rep. 2002, 2:216-222.
3. Goodpaster B.H., Wolf D. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatr. Diabetes 2004, 5:219-226.
4. Malecki M.T. Obesity-insulin resistance-type 2 diabetes mellitus. Kardiol. Pol. 2006, 64:S561-566.
5. N. Wolfson, D. Gavish, Z. Matas, M. Boaz, M. Shargorodsky, Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load, Exp. Diabetes Res. 2012 (2011).
6. Asghar Z., Yau D., Chan F., Leroith D., Chan C.B., Wheeler M.B. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes. Diabetologia 2006, 49:90-99.
7. Nonogaki K., Kumano H., Ootsuka Y., Takeuchi A., Nonogaki N., Kuboki T. Clinical worth of adiponectin levels in obesity and glycemic control of japanese type 2 diabetic patients. Diabetes Care 2003, 26:3198.
8. Degawa-Yamauchi M., Moss K.A., Bovenkerk J.E., Shankar S.S., Morrison C.L., Lelliott C.J., Vidal-Puig A., Jones R., Considine R.V. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes. Res. 2005, 13:662-669.
9. D.C. Tiziana, A. Christiano, C. Salvatore, S. Rosario, L. Giuseppe, Hypoadiponectinemia: a link between visceral obesity and metabolic syndrome, J. Nutr. Metab. 2012 (2011).
10. Ding M., Xie Y., Wagner R.J., Jin Y., Carrao A.C., Liu L.S., Guzman A.K., Powell R.J., Hwa J., Rzucidlo E.M. Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and foxO4. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1403-1410.
11. B. Wang, Y. Yu, L. Han, Adiponectin improves endothelial dysfunction caused by elevated FFAs levels, partially through cAMP-dependent pathway, Diabetes Res. Clin. Pract. (2012).
12. Kim C.H., Pennisi P., Zhao H., Yakar S., Kaufman J.B., Iganaki K., Shiloach J., Scherer P.E., Quon M.J., LeRoith D. MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E298-305.
13. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8:1288-1295.
14. Masaki T., Chiba S., Yasuda T., Tsubone T., Kakuma T., Shimomura I., Funahashi T., Matsuzawa Y., Yoshimatsu H. Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice. Diabetes 2003, 52:2266-2273.
15. Seo J.B., Moon H.M., Noh M.J., Lee Y.S., Jeong H.W., Yoo E.J., Kim W.S., Park J., Youn B.S., Kim J.W., Park S.D., Kim J.B. Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J. Biol. Chem. 2004, 279:22108-22117.
16. Musri M.M., Corominola H., Casamitjana R., Gomis R., Parrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J. Biol. Chem. 2006, 281:17180-17188.
17. Kim H.B., Kim W.H., Han K.L., Park J.H., Lee J., Yeo J., Jung M.H. CAMP-response element binding protein (CREB) positively regulates mouse adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2010, 391:634-639.
18. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2. Science 2001, 292:1728-1731.
19. Garofalo R.S., Orena S.J., Rafidi K., Torchia A.J., Stock J.L., Hildebrandt A.L., Coskran T., Black S.C., Brees D.J., Wicks J.R., McNeish J.D., Coleman K.G. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 2003, 112:197-208.
20. Gosmanov A.R., Umpierrez G.E., Karabell A.H., Cuervo R., Thomason D.B. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E8-E15.
21. Wang C., Mao X., Wang L., Liu M., Wetzel M.D., Guan K.L., Dong L.Q., Liu F. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J. Biol. Chem. 2007, 282:7991-7996.
22. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., Funahashi T., Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 2004, 279:1304.
23. Wang C., Xin X., Xiang R., Ramos F.J., Liu M., Lee H.J., Chen H., Mao X., Kikani C.K., Liu F., Dong L.Q. Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J. Biol. Chem. 2009, 284:31608-31615.
24. Wijesekara N., Krishnamurthy M., Bhattacharjee A., Suhail A., Sweeney G., Wheeler M. Adiponectin induced erk and akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J. Biol. Chem. 2010, 285:33621-33631.
25. Lawson M.A., Purslow P.P. Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cell. Tissue Organs 2000, 167:130-137.
26. Calvo J.C., Rodbard D., Katki A., Chernick S., Yanagishita M. Differentiation of 3T3-L1 preadipocytes with 3-isobutyl-1-methylxanthine and dexamethasone stimulates cell-associated and soluble chondroitin 4-sulfate proteoglycans. J. Biol. Chem. 1991, 266:11237-11244.
27. Firulli A.B., Han D., Kelly-Roloff L., Koteliansky V.E., Schwartz S.M., Olson E.N., Miano J.M. A comparative molecular analysis of four rat smooth muscle cell lines. In Vitro Cell Dev. Biol. Anim. 1998, 34:217-226.
28. Fang X., Palanivel R., Zhou X., Liu Y., Xu A., Wang Y., Sweeney G. Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J. Mol. Endocrinol. 2005, 35:465.
29. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 2005, 26:439-451.
30. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., Lodish H.F. Proteolytic cleavage product of 30kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Nat. Acad. Sci. U.S.A. 2001, 98:2005-2010.
31. Waki H., Yamauchi T., Kamon J., Kita S., Ito Y., Hada Y., Uchida S., Tsuchida A., Takekawa S., Kadowaki T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2005, 146:790-796.
32. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., Uchida S., Ito Y., Takakuwa K., Matsui J., Takata M., Eto K., Terauchi Y., Komeda K., Tsunoda M., Murakami K., Ohnishi Y., Naitoh T., Yamamura K., Ueyama Y., Froguel P., Kimura S., Nagai R., Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 2003, 278:2461-2468.